Form 4: Cerence EVP Schanz Granted 90,252 Restricted Stock Units

Cerence Inc.'s EVP of Product & Technology, Nils Schanz, was granted 90,252 restricted stock units, vesting over three years.

Summary

• Nils Schanz, Executive Vice President of Product & Technology at Cerence Inc. (CRNC), was granted 90,252 shares of common stock.
• The transaction occurred on October 1, 2025, with a nominal acquisition price of $0.01 per share.
• These shares are Restricted Stock Units (RSUs) subject to a Restricted Stock Unit Agreement.
• The RSUs will vest in three equal installments: one-third on October 1, 2026, one-third on October 1, 2027, and the final one-third on October 1, 2028.
• Following this transaction, Nils Schanz beneficially owns 235,541 shares of Cerence Inc. common stock.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a key executive is generally a positive signal, indicating management alignment with shareholder interests and a commitment to long-term retention. It is a standard compensation practice.

Positives

• The grant of Restricted Stock Units aligns the interests of a key executive, Nils Schanz, with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The multi-year vesting schedule (through October 2028) acts as a retention mechanism, incentivizing the executive to remain with the company and contribute to long-term value creation.

Negatives

• The issuance of 90,252 new shares upon vesting will result in a minor dilution of existing shareholder equity, though this is a standard component of executive compensation plans.

Future Outlook

The vesting schedule for the Restricted Stock Units extends through October 2028, indicating a long-term commitment and incentive structure for the EVP of Product & Technology.

Industry Context

The grant of Restricted Stock Units to a key executive like an EVP of Product & Technology is a common practice in the technology and software industry. It serves to attract, retain, and motivate top talent by linking their compensation directly to the company's stock performance and long-term success, which is crucial in competitive sectors like AI-powered automotive solutions where Cerence operates.

Comparison to Industry Standards

• This RSU grant is consistent with typical executive compensation practices observed across publicly traded technology companies, including peers like Nuance Communications (prior to acquisition), SoundHound AI, and other software providers.
• The multi-year vesting schedule is a standard mechanism to ensure executive retention and align interests with long-term shareholder value, comparable to similar equity incentive plans at companies such as Microsoft or Google for their senior leadership.

Stakeholder Impact

• Shareholders: The grant aligns executive incentives with shareholder value creation, but also entails minor future dilution upon vesting.
• Employees: May signal stability in executive leadership and a commitment to retaining key talent, potentially boosting morale.
• Management: Provides a significant long-term incentive and compensation component tied to company performance.

Next Steps

• The granted Restricted Stock Units will vest in three equal tranches on October 1, 2026, October 1, 2027, and October 1, 2028.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (RSU grant) which, while positive for management alignment, does not fundamentally alter the company's financial outlook or strategic direction to warrant a change in investment recommendation. It is an expected part of ongoing operations.

Keywords

Cerence Inc., CRNC, Nils Schanz, Restricted Stock Units, RSU grant, insider transaction, executive compensation, Form 4, equity award